Semmax Financial Advisors’s Eli Lilly LLY Stock Holding History

Semmax Financial Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$101K	Buy	162 +1	+0.6%	+$777	0.03%	156
2025 Q1	$118K	Hold	161	–	–	0.03%	139
2024 Q4	$140K	Hold	161	–	–	0.04%	131
2024 Q3	$132K	Sell	161 -2	-1%	-$1.8K	0.04%	128
2024 Q2	$148K	Buy	163 +6	+4%	+$4.8K	0.04%	128
2024 Q1	$119K	Buy	157 +74	+89%	+$52.7K	0.04%	127
2023 Q4	$61.8K	Hold	83	–	–	0.02%	135
2023 Q3	$50.9K	Buy	+83	New	+$42.8K	0.02%	118
2020 Q2	–	Sell	-25	Closed	-$3K	–	281
2020 Q1	$3K	Buy	+25	New	+$3.44K	﹤0.01%	210

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Semmax Financial Advisors's LLY Position: Q2 2025 in Review

Semmax Financial Advisors increased its Eli Lilly (LLY) stake by 0.62% in Q2 2025, buying an estimated $777 and bringing the position to 162 shares worth $101K. The position accounts for 0.03% of the portfolio, ranked #156.

Semmax Financial Advisors first reported a position in LLY in Q1 2020 and has held it in 9 quarters since. The position peaked at $148K in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

Semmax Financial Advisors held 162 shares of Eli Lilly worth $101K as of Q2 2025.
Semmax Financial Advisors bought 1 Eli Lilly share in Q2 2025, an estimated $777.
Eli Lilly made up 0.03% of Semmax Financial Advisors's portfolio in Q2 2025, its #156 holding.
Semmax Financial Advisors first reported a position in Eli Lilly in Q1 2020 and has held it in 9 quarters since.
Semmax Financial Advisors's Eli Lilly position peaked at $148K in Q2 2024.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Semmax Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.